These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31039139)

  • 1. Intracellular cholesterol biosynthesis in enchondroma and chondrosarcoma.
    Zhang H; Wei Q; Tsushima H; Puviindran V; Tang YJ; Pathmanapan S; Poon R; Ramu E; Al-Jazrawe M; Wunder J; Alman BA
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations.
    Zhang H; Puviindran V; Nadesan P; Ding X; Shen L; Tang YJ; Tsushima H; Yahara Y; Ban GI; Zhang GF; Karner CM; Alman BA
    J Bone Miner Res; 2022 May; 37(5):983-996. PubMed ID: 35220602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.
    Pathmanapan S; Poon R; De Renshaw TB; Nadesan P; Nakagawa M; Seesankar GA; Ho Loe AK; Zhang HH; Guinovart JJ; Duran J; Newgard CB; Wunder JS; Alman BA
    Cell Rep; 2023 Jun; 42(6):112578. PubMed ID: 37267108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
    Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
    Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
    Zhang L; Yang M; Mayer T; Johnstone B; Les C; Frisch N; Parsons T; Mi QS; Gibson G
    Connect Tissue Res; 2017 Mar; 58(2):155-161. PubMed ID: 27267924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines.
    Suijker J; Oosting J; Koornneef A; Struys EA; Salomons GS; Schaap FG; Waaijer CJ; Wijers-Koster PM; Briaire-de Bruijn IH; Haazen L; Riester SM; Dudakovic A; Danen E; Cleton-Jansen AM; van Wijnen AJ; Bovée JV
    Oncotarget; 2015 May; 6(14):12505-19. PubMed ID: 25895133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
    Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
    J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
    Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
    Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
    Joseph NM; McGill KC; Horvai AE
    Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
    Grifone TJ; Haupt HM; Podolski V; Brooks JJ
    Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
    Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
    Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
    Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
    Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
    Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
    Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enchondromatosis and Growth Plate Development.
    Zhang H; Alman BA
    Curr Osteoporos Rep; 2021 Feb; 19(1):40-49. PubMed ID: 33306166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
    Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC
    PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of
    Zhou S; Li Y; Qiao L; Ge Y; Huang X; Gao X; Ju H; Wang W; Zhang J; Yan J; Teng H; Jiang Q
    FASEB J; 2019 Aug; 33(8):9476-9488. PubMed ID: 31091421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal chromosome abnormalities in enchondromas and chondrosarcomas.
    Gunawan B; Weber M; Bergmann F; Wildberger J; Niethard FU; Füzesi L
    Cancer Genet Cytogenet; 2000 Jul; 120(2):127-30. PubMed ID: 10942802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.